These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 22826357)

  • 1. The plasma concentration of HDL-associated apoM is influenced by LDL receptor-mediated clearance of apoB-containing particles.
    Christoffersen C; Benn M; Christensen PM; Gordts PLSM; Roebroek AJM; Frikke-Schmidt R; Tybjaerg-Hansen A; Dahlbäck B; Nielsen LB
    J Lipid Res; 2012 Oct; 53(10):2198-2204. PubMed ID: 22826357
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Apolipoprotein M binds oxidized phospholipids and increases the antioxidant effect of HDL.
    Elsøe S; Ahnström J; Christoffersen C; Hoofnagle AN; Plomgaard P; Heinecke JW; Binder CJ; Björkbacka H; Dahlbäck B; Nielsen LB
    Atherosclerosis; 2012 Mar; 221(1):91-7. PubMed ID: 22204862
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decreased plasma concentrations of apolipoprotein M in sepsis and systemic inflammatory response syndromes.
    Kumaraswamy SB; Linder A; Åkesson P; Dahlbäck B
    Crit Care; 2012 Dec; 16(2):R60. PubMed ID: 22512779
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of apolipoprotein M on high density lipoprotein metabolism and atherosclerosis in low density lipoprotein receptor knock-out mice.
    Christoffersen C; Jauhiainen M; Moser M; Porse B; Ehnholm C; Boesl M; Dahlbäck B; Nielsen LB
    J Biol Chem; 2008 Jan; 283(4):1839-47. PubMed ID: 18006500
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Opposing effects of apolipoprotein m on catabolism of apolipoprotein B-containing lipoproteins and atherosclerosis.
    Christoffersen C; Pedersen TX; Gordts PL; Roebroek AJ; Dahlbäck B; Nielsen LB
    Circ Res; 2010 May; 106(10):1624-34. PubMed ID: 20360257
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isolation and characterization of human apolipoprotein M-containing lipoproteins.
    Christoffersen C; Nielsen LB; Axler O; Andersson A; Johnsen AH; Dahlbäck B
    J Lipid Res; 2006 Aug; 47(8):1833-43. PubMed ID: 16682745
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatic apolipoprotein M (apoM) overexpression stimulates formation of larger apoM/sphingosine 1-phosphate-enriched plasma high density lipoprotein.
    Liu M; Seo J; Allegood J; Bi X; Zhu X; Boudyguina E; Gebre AK; Avni D; Shah D; Sorci-Thomas MG; Thomas MJ; Shelness GS; Spiegel S; Parks JS
    J Biol Chem; 2014 Jan; 289(5):2801-14. PubMed ID: 24318881
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma levels of sphingosine-1-phosphate and apolipoprotein M in patients with monogenic disorders of HDL metabolism.
    Karuna R; Park R; Othman A; Holleboom AG; Motazacker MM; Sutter I; Kuivenhoven JA; Rohrer L; Matile H; Hornemann T; Stoffel M; Rentsch KM; von Eckardstein A
    Atherosclerosis; 2011 Dec; 219(2):855-63. PubMed ID: 21944699
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stable Isotope Kinetic Study of ApoM (Apolipoprotein M).
    Croyal M; Billon-Crossouard S; Goulitquer S; Aguesse A; León L; Fall F; Chétiveaux M; Moyon T; Blanchard V; Ouguerram K; Lambert G; Nobécourt E; Krempf M
    Arterioscler Thromb Vasc Biol; 2018 Jan; 38(1):255-261. PubMed ID: 29146748
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apolipoprotein M: Research progress, regulation and metabolic functions (Review).
    Huang LZ; Gao JL; Pu C; Zhang PH; Wang LZ; Feng G; Zhang Y
    Mol Med Rep; 2015 Aug; 12(2):1617-24. PubMed ID: 25901639
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Shift in ApoM/S1P Between HDL-Particles in Women With Type 1 Diabetes Mellitus Is Associated With Impaired Anti-Inflammatory Effects of the ApoM/S1P Complex.
    Frej C; Mendez AJ; Ruiz M; Castillo M; Hughes TA; Dahlbäck B; Goldberg RB
    Arterioscler Thromb Vasc Biol; 2017 Jun; 37(6):1194-1205. PubMed ID: 28385702
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LDL receptor and ApoE are involved in the clearance of ApoM-associated sphingosine 1-phosphate.
    Kurano M; Tsukamoto K; Hara M; Ohkawa R; Ikeda H; Yatomi Y
    J Biol Chem; 2015 Jan; 290(4):2477-88. PubMed ID: 25505264
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endothelial lipase promotes the catabolism of ApoB-containing lipoproteins.
    Broedl UC; Maugeais C; Millar JS; Jin W; Moore RE; Fuki IV; Marchadier D; Glick JM; Rader DJ
    Circ Res; 2004 Jun; 94(12):1554-61. PubMed ID: 15117821
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of apoM in normal and genetically modified mice.
    Faber K; Axler O; Dahlbäck B; Nielsen LB
    J Lipid Res; 2004 Jul; 45(7):1272-8. PubMed ID: 15102887
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The signal peptide anchors apolipoprotein M in plasma lipoproteins and prevents rapid clearance of apolipoprotein M from plasma.
    Christoffersen C; Ahnström J; Axler O; Christensen EI; Dahlbäck B; Nielsen LB
    J Biol Chem; 2008 Jul; 283(27):18765-72. PubMed ID: 18460466
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Apolipoprotein M promotes mobilization of cellular cholesterol in vivo.
    Elsøe S; Christoffersen C; Luchoomun J; Turner S; Nielsen LB
    Biochim Biophys Acta; 2013 Jul; 1831(7):1287-92. PubMed ID: 24046869
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endothelium-protective sphingosine-1-phosphate provided by HDL-associated apolipoprotein M.
    Christoffersen C; Obinata H; Kumaraswamy SB; Galvani S; Ahnström J; Sevvana M; Egerer-Sieber C; Muller YA; Hla T; Nielsen LB; Dahlbäck B
    Proc Natl Acad Sci U S A; 2011 Jun; 108(23):9613-8. PubMed ID: 21606363
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transforming growth factor-beta down-regulates apolipoprotein M in HepG2 cells.
    Xu N; Hurtig M; Zhang XY; Ye Q; Nilsson-Ehle P
    Biochim Biophys Acta; 2004 Jul; 1683(1-3):33-7. PubMed ID: 15238217
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Resveratrol exerts a biphasic effect on apolipoprotein M.
    Kurano M; Hara M; Nojiri T; Ikeda H; Tsukamoto K; Yatomi Y
    Br J Pharmacol; 2016 Jan; 173(1):222-33. PubMed ID: 26445217
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vascular endothelial growth factor downregulates apolipoprotein M expression by inhibiting Foxa2 in a Nur77-dependent manner.
    Hu YW; Zheng L; Wang Q; Zhong TY; Yu X; Bao J; Cao NN; Li B; Si-Tu B
    Rejuvenation Res; 2012 Aug; 15(4):423-34. PubMed ID: 22877565
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.